A detailed history of Fmr LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Fmr LLC holds 5,172 shares of CVRX stock, worth $44,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,172
Previous 3,200 61.63%
Holding current value
$44,944
Previous $58,000 6.9%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.49 - $19.2 $12,798 - $37,862
1,972 Added 61.63%
5,172 $62,000
Q1 2024

May 13, 2024

BUY
$17.99 - $30.49 $36,951 - $62,626
2,054 Added 179.23%
3,200 $58,000
Q4 2023

Feb 13, 2024

SELL
$11.67 - $33.01 $35,838 - $101,373
-3,071 Reduced 72.82%
1,146 $36,000
Q3 2023

Nov 13, 2023

BUY
$13.56 - $18.47 $67 - $92
5 Added 0.12%
4,217 $63,000
Q2 2023

Aug 11, 2023

BUY
$8.57 - $15.44 $31,666 - $57,050
3,695 Added 714.7%
4,212 $65,000
Q3 2022

Nov 10, 2022

SELL
$6.12 - $9.5 $195 - $304
-32 Reduced 5.83%
517 $5,000
Q2 2022

Aug 12, 2022

BUY
$4.7 - $7.22 $836 - $1,285
178 Added 47.98%
549 $3,000
Q1 2022

May 13, 2022

BUY
$5.62 - $12.37 $2,085 - $4,589
371 New
371 $2,000

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $179M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.